Navigation Links
Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
Date:11/9/2007

Technology shown to kill 99.9% of specific common pathogens known to cause

catheter-related blood stream infections, including MRSA

DEERFIELD, Ill., Nov. 9 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its V-Link Luer-activated device (LAD) with VitalShield protective coating. V-Link with VitalShield is the first needleless IV connector containing an antimicrobial coating. This new device has been shown to kill 99.9 percent of specific common pathogens (infection- causing microorganisms) known to cause catheter-related blood stream infections, including the highly treatment-resistant bacteria called methicillin-resistant Staphylococcus aureus, or MRSA. The Centers for Disease Control and Prevention (CDC) recently reported that MRSA infections cause an estimated 18,650 deaths per year in the United States (U.S.), which is more deaths in the U.S. per year than HIV/AIDS.

Baxter plans to launch the V-Link device with VitalShield coating in the U.S. beginning in the first half of 2008 and will expand to global markets later in the year.

"We are very pleased to receive market clearance for V-Link with VitalShield, which is the first in a series of new products Baxter's Medication Delivery business will be introducing over the next year to help reduce risks associated with IV therapy. This innovative technology represents the latest achievement in Baxter's long-standing history of bringing clinical practice-changing IV systems to market," said Camille Farhat, general manager of Global Infusion Systems, part of Baxter's Medication Delivery business. "We believe this technology will provide healthcare professionals with a greater ability to combat pathogens and make healthcare facilities safer environments for patients and clinicians."

"Catheter-related blood stream infections are a daunting challenge for the global healthc
'/>"/>

SOURCE Baxter Healthcare Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. IsoTis Receives FDA Clearance for Accell Family of Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... May 21, 2012 Genesis Biopharma, Inc. ... immunotherapies, announces the posting of the following Letter ... Company,s website at www.genesis-biopharma.com .  In addition, ... the U.S. Securities and Exchange Commission its Quarterly ... 2012 on Form 10-Q.  The Form 10-Q includes ...
(Date:5/18/2012)... DIEGO, May 18, 2012 Sequenom, Inc. (NASDAQ: ... innovative genetic analysis solutions, today announced that a new ... study on the Sequenom Center for Molecular Medicine,s (Sequenom ... been published online in the peer-reviewed journal, Prenatal ... announces that as of the week ended May 12, ...
(Date:5/16/2012)... 2011, nearly fifteen years after she became paralyzed and ... by thinking about moving her arm and hand to ... take a drink. That achievement is one of the ... technology described in the May 17 edition of the ... researchers at the Department of Veterans Affairs, Brown University, ...
(Date:5/16/2012)... ANAHEIM, Calif., May 16, 2012  Questcor Pharmaceuticals, ... that its Board of Directors has increased the ... additional 5 million shares. Since the ... million to shareholders through the repurchase of approximately ... 27% of its shares as of the commencement ...
Breaking Biology Technology:Genesis Biopharma Issues Letter To Shareholders 2Genesis Biopharma Issues Letter To Shareholders 3Genesis Biopharma Issues Letter To Shareholders 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 2Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 3Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 5People with paralysis control robotic arms to reach and grasp using brain computer interface 2People with paralysis control robotic arms to reach and grasp using brain computer interface 3People with paralysis control robotic arms to reach and grasp using brain computer interface 4People with paralysis control robotic arms to reach and grasp using brain computer interface 5Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5
... CHAPEL HILL, N.C., June 18 To thrive ... need to,understand that a winning sales performance doesn,t ... their sales forces, then,measure the forces, field-performance to ... research study reveals that best-in-class,companies allow their sales ...
... Inc. (OTC Bulletin Board: SYVC), a specialty,pharmaceutical company, ... LLC (Kirk) during the past year has added ... clients that includes Target,Walgreens, Family Dollar, HEB and ... are all over-the-counter (OTC) private label or "store,brand" ...
... CHESHIRE, Conn., June 18 Alexion,Pharmaceuticals, Inc. (Nasdaq: ... Officer of Alexion Pharmaceuticals, will present at the,Jefferies & ... at 4:15,p.m., ET on Wednesday, June 25, 2008., ... available live. You can,access the webcast at: http://www.alexionpharm.com ...
Other Biology Technology:Increasing Sales Productivity Through Superior Sales Force Performance Management 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 3Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 4Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 5
(Date:5/21/2012)... Purdue University are working with the U.S. Army ... Center to create a new type of "bioactive" coating ... caused by head trauma from bomb blasts. , "Stents ... the site of an aneurism to help heal the ... Allain, an associate professor of nuclear engineering. "Aneurisms are ...
(Date:5/21/2012)... mercury in plants and animals, a new study by ... Aquarium has compared levels of the chemical in captive ... animals were fed a controlled diet, while the wild ... of the toxic metal., The study found lower levels ... wild dolphins tested off the Atlantic and Gulf coasts ...
(Date:5/21/2012)... a combination of cues in their hunting sequence - capture, ... catch and consume and which ones they are better off ... first listen to their prey, then they assess its size, ... Page and her team from the Smithsonian Tropical Research Institute ... - The Science of Nature . , To survive, predators ...
Breaking Biology News(10 mins):Purdue professor to speak before Congress about nanotechnology in brain treatment research 2Purdue professor to speak before Congress about nanotechnology in brain treatment research 3Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 2Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 3What sounds good doesn't always taste good 2Henry Ford physicist awarded for cancer radiation therapy research 76678 1Henry Ford physicist awarded for cancer radiation therapy research 76678 2Study identifies flaws in Medicare prescription drug program 76676 1Study identifies flaws in Medicare prescription drug program 76676 2American Chemical Society co hosts Science and Society discussion on food safety on Nov 1 76674 1American Chemical Society co hosts Science and Society discussion on food safety on Nov 1 76674 2
... A study of populations of tiny water fleas is ... predictions about the ecological consequences of environmental change. , The ... Nature . The water flea, called Daphnia, plays a key ... Roger Nisbet, an ecologist based at the University of California, ...
... 30, 2008) The world,s rarest big cat is alive ... according to researchers from the Wildlife Conservation Society (WCS) who ... last week., The capture was made in Primorsky Krai along ... and the Russian Academy of Sciences Institute of Biology and ...
... in developing a water treatment system for industrial oil ... other commercially available tertiary treatments, leaving water so clean ... without endangering flora or fauna. , Wastewater from ships, ... with toxic compounds. Stringent EU regulations apply to its ...
Other Biology News:Studies of small water fleas help ecologists understand population dynamics 2World's rarest big cat gets a check-up 2World's rarest big cat gets a check-up 3Cleaning heavily polluted water at a fraction of the cost 2Cleaning heavily polluted water at a fraction of the cost 3
adult...
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...
... Guinea Pig serum is collected from fasted Guinea ... Citrate N-04: Heparin (Na) ... N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: ...
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Biology Products: